First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors
Clinical trial NCT07686068 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686068
- Sponsor
- VelaVigo Bio Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-18
- Primary completion
- 2028-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.